Inhibition of angiogenesis as a strategy for tumor growth control
- 1 February 1994
- journal article
- review article
- Published by Springer Nature in Molecular and Chemical Neuropathology
- Vol. 21 (2) , 329-336
- https://doi.org/10.1007/bf02815359
Abstract
Angiogenesis is a complex sequence of events leading to the formation of new capillaries. Although essential to maturation and wound healing, most angiogenesis in the adult is associated with pathological events, such as the development of solid tumors. One approach to the inhibition of angiogenesis is the antagonism of basic fibroblast growth factor, a major angiogenic protein. Evidence is reviewed to suggest that inhibiting angiogenesis results in the suppression of tumor growth.Keywords
This publication has 20 references indexed in Scilit:
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growthJournal of Neuroscience Research, 1990
- Specific inhibition of endothelial cell proliferation by thrombospondinBiochemical and Biophysical Research Communications, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- A new activity of herbimycin A: Inhibition of angiogenesis.The Journal of Antibiotics, 1989
- Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).The Journal of Antibiotics, 1989
- Angiogenic FactorsScience, 1987
- Chemical modification of herbimycin A. Synthesis and in vivo antitumor activities of halogenated and other related derivatives of herbimycin A.The Journal of Antibiotics, 1986
- Anti-AngiogenesisAnnals of Surgery, 1972
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971